- Home
- XCUR vs SRZN Comparison
XCUR vs SRZN Comparison
Compare XCUR & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- SRZN
- Stock Information
- Founded
- XCUR 2011
- SRZN 2015
- Country
- XCUR United States
- SRZN United States
- Employees
- XCUR N/A
- SRZN N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- XCUR Health Care
- SRZN Health Care
- Exchange
- XCUR Nasdaq
- SRZN Nasdaq
- Market Cap
- XCUR 74.1M
- SRZN 82.8M
- IPO Year
- XCUR N/A
- SRZN N/A
- Fundamental
- Price
- XCUR $11.38
- SRZN $8.60
- Analyst Decision
- XCUR
- SRZN Strong Buy
- Analyst Count
- XCUR 0
- SRZN 2
- Target Price
- XCUR N/A
- SRZN $38.50
- AVG Volume (30 Days)
- XCUR 31.6K
- SRZN 10.0K
- Earning Date
- XCUR 06-16-2025
- SRZN 05-20-2025
- Dividend Yield
- XCUR N/A
- SRZN N/A
- EPS Growth
- XCUR N/A
- SRZN N/A
- EPS
- XCUR N/A
- SRZN N/A
- Revenue
- XCUR $500,000.00
- SRZN $10,655,000.00
- Revenue This Year
- XCUR N/A
- SRZN N/A
- Revenue Next Year
- XCUR N/A
- SRZN N/A
- P/E Ratio
- XCUR N/A
- SRZN N/A
- Revenue Growth
- XCUR N/A
- SRZN N/A
- 52 Week Low
- XCUR $1.44
- SRZN $6.00
- 52 Week High
- XCUR $36.00
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- XCUR 51.56
- SRZN 35.15
- Support Level
- XCUR $9.81
- SRZN $9.96
- Resistance Level
- XCUR $11.58
- SRZN $11.56
- Average True Range (ATR)
- XCUR 1.00
- SRZN 0.67
- MACD
- XCUR 0.02
- SRZN -0.08
- Stochastic Oscillator
- XCUR 58.32
- SRZN 2.31
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).